Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

During the Trading Day
5.72 -0.23 / -3.87%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.72 0.00 / 0.00%
 
Volume: 1.9K

Today’s Trading

Previous close5.95
Today’s open5.97
Day’s range5.51 - 6.08
Volume474,672
Average volume (3 months)776,238
Market cap$176.3M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-46.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales292.69
Price/Book13.48

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...-0.21-3.38%
TRILTrillium Therapeutic...-0.24-1.54%
CALACalithera Bioscience...-0.32-5.49%
CGIXCancer Genetics Inc-0.16-1.64%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

Partner Offers